drugset / Trial / NCT00357734
Iressa Follow-up Trial
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the long-term safety profile and the secondary objective to estimate clinical benefit of ZD1839 (gefitinib).
Timeline
- Start
- 2005-01
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | 250 mg | — |
| Subject | Gefitinib | Small molecule | 500 mg | — |